- DKK13.54bn
- DKK11.39bn
- DKK6.24bn
Bavarian Nordic rises nearly 5% after takeover price hike
Brief: Bavarian Nordic Maintains Recommendation On Takeover Offer
Nordic Capital-led consortium raises takeover price for Bavarian Nordic to $38.94 per share (updated)
Nordic Capital-led consortium raises takeover price for Bavarian Nordic to $38.94 per share
Brief: Bavarian Nordic Says Consortium Consisting Of Nordic Capital, Permira Increases Offer Price And Extends Offer Period Until 5 November In Respect Of Takeover Offer
Brief: Bavarian Nordic: Consortium Gets Final Regulatory Approval Of Takeover Offer
Brief: Bavarian Nordic Reports Positive Topline Data For Mpox/Smallpox Vaccine
Brief: Bavarian Nordic: Offer Period Extended To Oct 14
Permira seeks $4 billion for sale of contract drugmaker Cambrex, FT reports (updated)
Brief: Bavarian Nordic Says Innosera Lowers Minimum Acceptance Condition
Brief: Bavarian Nordic Bord Recommends Shareholders To Accept Offer From Innosera
Bavarian Nordic beats revenue expectations, as launch of takeover bid nears
Brief: Bavarian Nordic Keeps Rev Interval, EBITDA Margin Expectations For @025
Brief: Bavarian Nordic Upgrades 2025 Financial Guidance
Deals of the day-Mergers and acquisitions
Consortium led by Nordic Capital, Permira to buy vaccine maker Bavarian Nordic (updated)
Consortium led by Nordic Capital, Permira to acquire Bavarian Nordic
Brief: Consortium Led By Nordic Capital, Permira To Make DKK 233 Offer For Bavarian Nordic
Deals of the day-Mergers and acquisitions